Abstract

Abstract 4241Adult T-cell leukaemia/lymphoma (ATLL) is a highly aggressive malignancy with a poor prognosis caused by the human T-cell lymphotropic virus type-1 (HTLV-I). While no specific chromosome or genetic abnormalities have been clearly proven to contribute to the pathogenesis of ATLL, recent comparative genomic hybridization (CGH) studies have demonstrated frequent genetic lesions (gains and losses) involving specific chromosomal regions containing a number of genes of potential cancer relevance. In this study, using a high resolution Agilent platform, we performed a comprehensive CGH analysis of 60 ATLL DNA specimens obtained from individuals of African descent from the United States, the Caribbean, and Brazil. Our preliminary results demonstrate the presence of some alterations already reported by others, such as gains in chromosomes 1q22, 4p16, 7p22, 8q24, 9q33-34, 14q31-q32, 16q16, 18q23, 19p13 and deletions at 6q14, 9p21 and q21 and 14q11. Additionally, we have observed several genetic alterations not previously reported in a significant percentage of our ATLL tumors, such as specific gains in regions of chromosomes 1q, 2q, 5p, and 17p and q, and deletions in 13q and 15q. Most of these regions harbor potential cancer related genes but some contain genes of unknown function. Our preliminary results confirm there are common genetic alterations between ATLL patients of Japanese and African origin, but also distinct genetic lesions between both ethnic groups perhaps contributing to the pathogenesis of ATLL. A more comprehensive analysis including validated findings will be presented at the meeting. Disclosures:No relevant conflicts of interest to declare.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.